Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetes

Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetes

US Patent 12098179 · Granted Sep 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigenic peptides deriving from secretogranin V and uses thereof for the diagno2025
Antigenic peptides deriving from secretogranin V and uses thereof for the diagno2025
Antigenic peptides deriving from secretogranin V and uses thereof for the diagno2025
Antigenic peptides deriving from secretogranin V and uses thereof for the diagno2025
Antigenic peptides deriving from secretogranin V and uses thereof for the diagno2025
T cell receptors (TCR) and uses thereof for the diagnosis and treatment of diabe2021
T cell receptors (TCR) and uses thereof for the diagnosis and treatment of diabe2021
Methods and pharmaceutical compositions for inducing immune tolerance by mucosal2019
Methods for stimulating antigen-specific T cell responses2017
Methods for stimulating antigen-specific T cell responses2017
Method for stimulating antigen-specific T cell responses using accelerated co-cu2015